{"id":34707,"date":"2017-05-24T21:35:11","date_gmt":"2017-05-24T20:35:11","guid":{"rendered":"https:\/\/bioengineer.org\/utas-abexxa-biologics-named-one-of-40-best-university-startups-2017-by-ncet2\/"},"modified":"2017-05-24T21:35:11","modified_gmt":"2017-05-24T20:35:11","slug":"utas-abexxa-biologics-named-one-of-40-best-university-startups-2017-by-ncet2","status":"publish","type":"post","link":"https:\/\/bioengineer.org\/utas-abexxa-biologics-named-one-of-40-best-university-startups-2017-by-ncet2\/","title":{"rendered":"UTA’s AbeXXa Biologics named one of 40\u00a0Best University Startups 2017\u00a0by NCET2"},"content":{"rendered":"

(University of Texas at Arlington) AbeXXa Biologics, a faculty startup at The University of Texas at Arlington, was named one of the 40 'Best University Startups 2017' by the National Council of Entrepreneurial Tech Transfer. AbeXXa is identifying a new series of biomarkers or targets for cancer from the many thousands of proteins found within a tumor cell, a new field of research that could potentially result in immunotherapies that prove effective for a broad range of patients.<\/p>\n

############<\/p>\n

<\/p>\n

Story Source: <\/b>Materials<\/a> provided by Scienmag<\/span><\/strong><\/p>\n

\n","protected":false},"excerpt":{"rendered":"

(University of Texas at Arlington) AbeXXa Biologics, a faculty startup at The University of Texas at Arlington, was named one of the 40 'Best University Startups 2017' by the National Counci..<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"footnotes":""},"categories":[185],"tags":[],"class_list":["post-34707","post","type-post","status-publish","format-standard","hentry","category-science-news"],"_links":{"self":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/34707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/comments?post=34707"}],"version-history":[{"count":0,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/34707\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/media?parent=34707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/categories?post=34707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/tags?post=34707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} BIOENGINEER.ORG

Page 1 of 7687 1 2 7,687